ASO Author Reflections: Beyond the Binary: Using IHC Status to Predict Response to Neoadjuvant Therapy in HER2+ Early-Stage Breast Cancer.

Saved in:
Bibliographic Details
Title: ASO Author Reflections: Beyond the Binary: Using IHC Status to Predict Response to Neoadjuvant Therapy in HER2+ Early-Stage Breast Cancer.
Authors: Winer LK; Division of Surgical Oncology, Department of Surgery, University of Kentucky, Lexington, KY, USA.; Division of Breast Surgery, Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Williams AD; Division of Breast Surgery, Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA. Austin.Williams@fccc.edu.
Source: Annals of surgical oncology [Ann Surg Oncol] 2025 Feb; Vol. 32 (2), pp. 967-968. Date of Electronic Publication: 2024 Dec 02.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1534-4681
DOI:10.1245/s10434-024-16606-w